Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifford A Hudis

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Nature Clinical Practice. Oncology|January 13, 2006
Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancerClifford A Hudis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Science and society: Fifty years later--the 2014 presidential addressClifford A Hudis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Flashback Foreword: Preoperative Therapy for Operable Breast Cancer and Clinical Features of Triple-Negative Breast CancerClifford A Hudis
Breast (Edinburgh, Scotland)|August 11, 2015
Big data: Are large prospective randomized trials obsolete in the future?Clifford A Hudis
Oncology (Williston Park, N.Y.)|June 7, 2005
Clinical implications of antiangiogenic therapiesClifford A Hudis
Science Translational Medicine|September 6, 2013
Sequester cuts may delay drug approvals--and moreClifford A Hudis
Cancer Journal (Sudbury, Mass.)|February 19, 2010
From the guest editor: Triple-negative breast cancerClifford A Hudis
The New England Journal of Medicine|July 6, 2007
Trastuzumab--mechanism of action and use in clinical practiceClifford A Hudis
The New England Journal of Medicine|September 29, 2015
Biology before Anatomy in Early Breast Cancer--Precisely the PointClifford A Hudis
Clinical Breast Cancer|December 12, 2003
Current status and future directions in breast cancer therapyClifford A Hudis
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Nature Clinical Practice. Oncology|January 13, 2006
Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancerClifford A Hudis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Science and society: Fifty years later--the 2014 presidential addressClifford A Hudis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Flashback Foreword: Preoperative Therapy for Operable Breast Cancer and Clinical Features of Triple-Negative Breast CancerClifford A Hudis
Breast (Edinburgh, Scotland)|August 11, 2015
Big data: Are large prospective randomized trials obsolete in the future?Clifford A Hudis
Oncology (Williston Park, N.Y.)|June 7, 2005
Clinical implications of antiangiogenic therapiesClifford A Hudis
Science Translational Medicine|September 6, 2013
Sequester cuts may delay drug approvals--and moreClifford A Hudis
Cancer Journal (Sudbury, Mass.)|February 19, 2010
From the guest editor: Triple-negative breast cancerClifford A Hudis
The New England Journal of Medicine|July 6, 2007
Trastuzumab--mechanism of action and use in clinical practiceClifford A Hudis
The New England Journal of Medicine|September 29, 2015
Biology before Anatomy in Early Breast Cancer--Precisely the PointClifford A Hudis
Clinical Breast Cancer|December 12, 2003
Current status and future directions in breast cancer therapyClifford A Hudis
Pageof 25